NM_007194.4:c.908+1G>C

Variant names:

• chr22-28703504-C-G
• rs587781699
• NM_007194.4:c.908+1G>C

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1 PM2 PP5_Very_Strong

The NM_007194.4(CHEK2):​c.908+1G>C variant causes a splice donor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).

• Frequency: Genomes: not found (cov: 32)
• Consequence: CHEK2 NM_007194.4 splice_donor, intron
• Scores: Splicing: ADA: 1.000
• Clinical Significance: Likely pathogenic criteria provided, multiple submitters, no conflicts P:3
• Conservation: PhyloP100: 5.77
• Publications: 4 publications found

Genes affected

CHEK2 (HGNC:16627): (checkpoint kinase 2) In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

CHEK2 Gene-Disease associations (from GenCC):

• CHEK2-related cancer predisposition

  Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
• hereditary breast carcinoma

  Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
• Li-Fraumeni syndrome 2

  Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
• acute myeloid leukemia

  Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
• hereditary nonpolyposis colon cancer

  Inheritance: AD Classification: LIMITED Submitted by: ClinGen
• familial ovarian cancer

  Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

ACMG classification

Our verdict: Pathogenic. The variant received 18 ACMG points.

• PVS1: Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, No cryptic splice site detected. Exon removal results in frameshift change.
• PM2: Very rare variant in population databases, with high coverage
• PP5: Variant 22-28703504-C-G is Pathogenic according to our data. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28703504-C-G is described in CliVar as Likely_pathogenic. Clinvar id is 496347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
CHEK2	NM_007194.4	c.908+1G>C		splice_donor_variant, intron_variant	Intron 8 of 14	ENST00000404276.6	NP_009125.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
CHEK2	ENST00000404276.6	c.908+1G>C		splice_donor_variant, intron_variant	Intron 8 of 14	1	NM_007194.4	ENSP00000385747.1

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Cov.: 19

GnomAD4 genome Cov.: 32

ClinVar

Significance: Likely pathogenic

Submissions summary: Pathogenic:3

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

Familial cancer of breast Pathogenic:2

Jun 27, 2023

Myriad Genetics, Inc.

Significance: Likely pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is considered likely pathogenic. This variant occurs within a consensus splice junction and is predicted to result in abnormal mRNA splicing of either an out-of-frame exon or an in-frame exon necessary for protein stability and/or normal function. -

Jul 23, 2024

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Likely pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This sequence change affects a donor splice site in intron 8 of the CHEK2 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or altered protein product. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with prostate cancer (PMID: 31214711, 32832836). ClinVar contains an entry for this variant (Variation ID: 496347). Studies have shown that disruption of this splice site results in skipping of exon 8 , and produces a non-functional protein and/or introduces a premature termination codon (Invitae). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -

Hereditary breast ovarian cancer syndrome Pathogenic:1

Aug 21, 2017

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

Significance: Likely pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

Variant summary: The c.908+1G>C (aka IVS8+1G>C) in a CHEK2 gene is a splice-site variant that alters a highly conserved nucleotide. 5/5 in silico tools via Alamut predict this variant to disrupt a canonical donor sequence, however these predictions have yet to be confirmed by functional assay. The variant is absent from control datasets of ExAC and gnomAD (~29770 and 196838 chrs tested, respectively). The variant has not, to our knowledge, been reported in affected individuals via publications or cited as by a reputable database/clinical laboratory. Alteration on the same nucleotide, c.908+1G>A, has been reported in at least 3 BrC patients (Leedom, 2016) with classification of Likely Pathogenic. Taken together, the variant was classified as Likely Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_addAF	Pathogenic	0.42	D
BayesDel_noAF	Pathogenic	0.37
CADD	Pathogenic	31
DANN	Uncertain	1.0
Eigen	Pathogenic	1.1
Eigen_PC	Pathogenic	0.98
FATHMM_MKL	Pathogenic	0.97	D
PhyloP100		5.8
GERP RS		5.4
RBP_binding_hub_radar		0.0
RBP_regulation_power_radar		1.7
Mutation Taster		=0/100	disease causing (ClinVar)

Splicing

Name	Calibrated prediction	Score	Prediction
dbscSNV1_ADA	Pathogenic	1.0
dbscSNV1_RF	Pathogenic	0.94
SpliceAI score (max)		0.88		Details are displayed if max score is > 0.2
DS_DL_spliceai		0.88		Position offset: 1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs587781699; hg19: chr22-29099492;